1,192
Views
33
CrossRef citations to date
0
Altmetric
Reviews

The Role of Grape Seed Extract in the Treatment of Chemo/Radiotherapy Induced Toxicity: A Systematic Review of Preclinical Studies

, , &
Pages 730-740 | Received 25 Aug 2014, Accepted 10 Feb 2015, Published online: 16 Apr 2015

REFERENCES

  • Riboli E and Norat T: Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk. Am J Clin Nutr 78, 559–569, 2003.
  • Rossi M, Negri E, Parpinel M, Lagiou P, Bosetti C, et al.: Proanthocyanidins and the risk of colorectal cancer in Italy. Cancer Causes Control 2, 243–250, 2010.
  • World Cancer Research Fund/American Institute for Cancer Research: Food, Nutrition, Physical Activity and the Prevention of Cancer: a global perspective. Washington, DC: American Institute for Cancer Research, 2007.
  • Craig WJ and Mangels AR: Position of the American Dietetic Association: vegetarian diets. J Am Diet Assoc 109, 1266–1282, 2009.
  • Mittal A, Elmets CA, and Katiyar SK: Dietary feeding of proanthocyanidins from grape seeds prevents photocarcinogenesis in SKH-1 hairless mice: relationship to decreased fat and lipid peroxidation. Carcinogenesis 24, 1379–1388, 2003.
  • Meeran SM, Vaid M, Punathil T, and Katiyar SK: Dietary grape seed proanthocyanidins inhibit 12-O-tetradecanoyl phorbol-13-acetate-caused skin tumor promotion in 7,12-dimethylbenz(a)anthracene-initiated mouse skin, which is associated with the inhibition of inflammatory responses. Carcinogenesis 30, 520–5287, 2009.
  • Nandakumar V, Singh T, and Katiyar SK: Multi-targeted prevention and therapy of cancer by proanthocyanidins. Cancer Lett 269, 378–387, 2008.
  • Wang CZ, Fishbein A, Aung HH, Mehendale SR, Chang WT, et al.: Polyphenol contents in grape seed extracts correlate with antipica effects in cisplatin- treated rats. J Altern Complement Med 11, 1059–1065, 2005.
  • Curry HL, Parkes SE, Powell JE, and Mann JR: Caring for survivors of childhood cancers: the size of the problem. Eur J Cancer 2, 501–508, 2006.
  • Duncan M and Grant G: Oral and intestinal mucositis—causes and possible treatments. Aliment Pharmacol Ther 18, 853–874, 2003.
  • Vincent DT, Ibrahim YF, Espey MG, and Suzuki YT: The role of antioxidants in the era of cardio-oncology. Cancer Chemother Pharmacol 72, 1157–1168, 2013.
  • Spitz DR, Azzam EI, Li JJ, and Guis D: Metabolic oxidation/reduction reactions and cellular responses to ionizing radiation: a unifying concept in stress response biology. Cancer Metastasis Rev 23, 311–322, 2004.
  • Baliga MS, Jagetia GC, Venkatesh P, Reddy R, and Ulloor JN: Radioprotective effect of abana, a polyherbal drug following total body irradiation. Br J Radiol 77, 1027–1035, 2004.
  • Prasad KN, Cole WC, and Haase GM: Radiation protection in humans: extending the concept of as low as reasonably achievable (ALARA) from dose to biological damage. Br J Radiol 77, 97–99, 2004.
  • Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche, PC, et al.: The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339, b2700, 2009.
  • Moher D, Liberati A, Tetzlaff J, Altman DG, and The PRISMA Group: Preferred reporting items for systematic reviews and meta-analyses: The PRISMA Statement. Open Med 3, e123–e130, 2009.
  • van der Worp HB, Howells DW, Sena ES, Porritt MJ, Rewell S, et al.: Can animal models of disease reliably inform human studies? PLoS Med 7, e1000245, 2010.
  • El Ammar SM, Said SA, El-Damarawy SL, and Suddek GM: Cardioprotective effect of grape-seed proanthocyanidins on doxorubicin-induced cardiac toxicity in rats. Pharm Biol 51, 339–344, 2013.
  • El Boghdady NA: Antioxidant and antiapoptotic effects of proanthocyanidin and ginkgo biloba extract against doxorubicin-induced cardiac injury in rats. Cell Biochem Funct 31, 344–351, 2012.
  • Mokni M, Hamlaoui-Guesmi S, Amri M, Marzouki L, Limam F, et al.: Grape seed and skin extract protects against acute chemotherapy toxicity induced by doxorubicin in rat heart. Cardiovasc Toxicol 12, 158–165, 2012.
  • Ammar EM, Said SA, Suddek GM, and El-Damaraw SL: Assessment of cardiac toxicity of doxorubicin on the rat electrocardiogram and its prevention by drugs. Altex 28, 32, 2011.
  • Li J, Liu H, Ramachandran S, Waypa GB, Yin JJ, et al.: Grape seed proanthocyanidins ameliorate doxorubicin-induced cardiotoxicity. Am J Chin Med 38, 569–584, 2010.
  • Yalcin E, Oruc E, Cavusoglu K, and Yapar K: Protective role of grape seed extract against doxorubicin-induced cardiotoxicity and genotoxicity in albino mice. J Med Food 13, 917–925, 2010.
  • Bogdanovic G, Andric N, Stanic B, Canadanovic-Brunet J, Spasic M, et al.: The effects of proanthocyanidins on cardiotoxic and antitumour activity of doxorubicin. Eur J Cancer 8(Suppl.), 62–63, 2010.
  • Demirkaya E, Avci A, Kesik V, Karslioglu Y, Oztas E, et al.: Cardioprotective roles of aged garlic extract, grape seed proanthocyanidin, and hazelnut on doxorubicin-induced cardiotoxicity. Can J Physiol Pharmacol 87,633–640, 2009.
  • Li W, Xu B, Xu J, and Wu XL: Procyanidins produce significant attenuation of doxorubicin-induced cardiotoxicity via suppression of oxidative stress. Basic and Clinical Pharmacology and Toxicology 104, 192–197, 2009.
  • Du Y and Lou H: Catechin and proanthocyanidin B4 from grape seeds prevent doxorubicin-induced toxicity in cardiomyocytes. Eur J Pharmacol 4, 96–101, 2008.
  • Zhang XY, Li WG, Wu YJ, and Gao MT: Amelioration of doxorubicin-induced myocardial oxidative stress and immunosuppression by grape seed proanthocyanidins in tumour-bearing mice. Journal of Pharmacy and Pharmacology 57, 1043–1051, 2005.
  • Bagchi D, Ray SD, Patel D, and Bagchi M: Protection against drug- and chemical-induced multiorgan toxicity by a novel IH636 grape seed proanthocyanidin extract. Drugs Exptl Clin Res 27, 3–15, 2001.
  • Ray SD, Wong V, Rinkovsky A, Bagchi M, Raje RR, et al.: Unique organoprotective properties of a novel IH636 grape seed proanthocyanidin extract on cadmium chloride-induced nephrotoxicity, dimethylnitrosamine (DMN)-induced splenotoxicity and mocap-induced neurotoxicity in mice. Research Communications in Molecular Pathology and Pharmacology 107, 105–128, 2000.
  • Bagchi D, Ray SD, Bagchi M, Preuss HG, and Stohs SJ: Mechanistic pathways of antioxidant cytoprotection by a novel IH636 grape seed proanthocyanidin extract. Indian J Exp Biol 40, 717–726, 2004.
  • Hamlaoui S, Mokni M, Limam N, Carrier A, Limam F, et al.: Grape seed and skin extract protects against acute chemotherapy toxicity induced by doxorubicin in rat red blood cells and plasma. Bangladesh Journal of Pharmacology 7, 54–62, 2012.
  • De Rezende AA, Graf U, Guterres ZD, Kerr WE, and Spano MA: Protective effects of proanthocyanidins of grape (Vitis vinifera L.) seeds on DNA damage induced by Doxorubicin in somatic cells of Drosophila melanogaster. Food Chem Toxicol 47, 1466–1472, 2009.
  • Valls-Belles V, Torres MC, Muniz P, Beltran S, Martinez-Alvarez JR, et al.: Defatted milled grape seed protects adriamycin-treated hepatocytes against oxidative damage. Euro J Nutr 45, 251–258, 2006.
  • Attia SM, Al-Bakheet SA, and Al-Rasheed NM: Proanthocyanidins produce significant attenuation of doxorubicin-induced mutagenicity via suppression of oxidative stress. Oxid Med Cell Longev 3, 404–413, 2010.
  • Postescu ID, Chereches G, Tatomir C, Daicoviciu D, and Filip GA: Modulation of doxorubicin-induced oxidative stress by a grape (Vitis vinifera L.) seed extract in normal and tumor cells. J Med Food 15, 639–645, 2012.
  • Sayed AAR: Proanthocyanidin protects against cisplatin-induced nephrotoxicity. Phyto Res 23, 1738–1741, 2009.
  • Saad AA, Youssef MI, and El-Shennawy LK: Cisplatin induced damage in kidney genomic DNA and nephrotoxicity in male rats: The protective effect of grape seed proanthocyanidin extract. Food Chem Toxicol 47, 1499–1506, 2009.
  • Yousef MI, Saad AA, and El-Shennawy LK: Protective effect of grape seed proanthocyanidin extract against oxidative stress induced by cisplatin in rats. Food Chem Toxicol 47, 1176–1183, 2009.
  • Attia SM, Helal GK, Abd-Ellah MF, Mansour AM, and El-Sayed ES: The effects of oral grape seed extract on cisplatin-induced cytogenotoxicity in mice. Saudi Pharmaceutical Journal 16, 161–169, 2008.
  • Wang CZ, Fishbein A, Aung HH, Mehendale SR, Chang WT, et al.: Polyphenol contents in grape-seed extracts correlate with antipica effects in cisplatin-treated rats. J Alternative and Complementary Medicine 11, 1059–1065, 2005.
  • Gulgun M, Karaoglu A, Kesik V, Kurt B, Erdem O, et al.: Effect of proanthocyanidin, arginine and glutamine supplementation on methotrexate-induced gastrointestinal toxicity in rats. Experimental and Clinical Pharmacology 32, 657–661, 2010.
  • Gulgun M, Erdem O, Oztas E, Kesik V, Balamtekin N, et al.: Proanthocyanidin prevents methotrexate-induced intestinal damage and oxidative stress. Exptl Toxicol Path 62, 109–115, 2010.
  • Pinheiro FV, Pimentel VC, De Bona KS, Scola G, Salvador M, et al.: Decrease of adenosine deaminase activity and increase of the lipid peroxidation after acute methotrexate treatment in young rats: protective effects of grape seed extract. Cell Biochem Funct 28, 89–94, 2010.
  • Cetin A, Kaynar L, Kocyigit I, Hacioglu SK, Saraymen R, et al.: Role of grape seed extract on methotrexate induced oxidative stress in rat Liver. Am J Chin Med 36, 861–872, 2008.
  • Cheah KY, Bastian S, Acott T, and Howarth G: Grape seed extract: Effects on chemotherapy-induced mucositis and inflammatory bowel disease in rats. Supportive Care in Cancer 17, 905–906, 2009.
  • Cheah KY, Howarth GS, Yazbeck R, Wright TH, Whitford EJ, et al.: Grape seed extract protects IEC-6 cells from chemotherapy-induced cytotoxicity and improves parameters of small intestinal mucositis in rats with experimentally-induced mucositis. Cancer Biology and Therapy 8, 382–390, 2009.
  • Joshi SS, Kuszynski CA, and Bagchi D: The cellular and molecular basis of health benefits of grape seed proanthocyanidin extract. Current Pharmaceutical Biotechnology 2, 187–200, 2001.
  • Joshi SS, Kuszynski CA, Benner EJ, Bagchi M, and Bagchi D: Amelioration of the cytotoxic effects of chemotherapeutic agents by grape seed proanthocyanidin extract. Antioxid Redox Signal 1, 563–570, 1999.
  • Alcaraz M, Acevedo C, Castillo J, Benavente-Garcia O, Armero D, et al.: Liposoluble antioxidants provide an effective radioprotective barrier. British Journal of Radiology 82, 605–609, 2009.
  • Gao F, Li BL, Sun D, Huang YC, Ni J, et al.: Protective effects of proanthocyanidin on radiation-induced injury of human-derived cells. Academic Journal of Second Military Medical University 30, 641–644, 2009.
  • Saada HN, Said UZ, Meky NH, and Abd El Azime AS: Grape seed extract Vitis vinifera protects against radiation-induced oxidativedamage and metabolic disorders in rats. Phytother Res 23, 434–438, 2009.
  • Jiang BQ and Chang H: Protective effect of grape seed proanthocyanidin and casein peptide on intestinal mucosal barrier in rats with radiation injury. Chin J Clin Rehab 10, 121–123, 2006.
  • Chang H and Jiang BQ: Protective action of grape seed proanthocyanidins combined with casein on radiation damage of rats. Chin Jo Clin Rehab 9, 210–211, 2005.
  • Cetin A, Kaynar L, Kocyigit I, Hacioglu SK, Saraymen R, et al.: The effect of grape seed extract on radiation-induced oxidative stress in the rat liver. Turkish Journal of Gastroenterology 19, 92–98, 2008.
  • Enginar H, Cemek M, Karaca T, and Unak P: Effect of grape seed extract on lipid peroxidation, antioxidant activity and peripheral blood lymphocytes in rats exposed to x-radiation. Phytother Res 21, 1029–1035, 2007.
  • Liu HZ and Zhong JY: Inhibitory effect of grape procyanidin on the cell apoptosis induced by radiation. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 22, 448–451, 2004.
  • Castillo J, Benavente-García O, Lorente J, Alcaraz M, Redondo A, et al.: Antioxidant activity and radioprotective effects against chromosomal damage induced in vivo by X-rays of flavan-3-ols (Procyanidins) from grape seeds (Vitis vinifera): comparative study versus other phenolic and organic compounds. J Agric Food Chem 48, 1738–1745, 2000.
  • Theodore C, Bayle C, Bernheim A, and Wibault P: Secondary leukemia after advanced bladder cancer with methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy and radiotherapy. BJU Int 90, 470–471, 2002.
  • Smith RE: Risk for the development of treatment related acute myelocytic leukemia and myelodysplastic syndrome among patients with breast cancer: review of the literature and the National Surgical Adjunct Breast and Bowel Project experience. Clin Breast Cancer 4, 273–279, 2003.
  • Mistry AR, Felix CA, Whitmarsh RJ, Mason A, Reiter A, et al.: DNA topoisomerase II therapy related acute promyelocytic leukemia. N Engl J Med 352, 1529–1538, 2005.
  • Craford BA, Spaliviero JA, Simpson JM, and Handelsman DJ: Testing the gonadal regression-cytoprotection hypothesis. Cancer Research 58, 5105–5109, 1998.
  • Habertson J and Downey M: Know your phenolics. Australian Viticulture 10, 98–100, 2006.
  • Gu L, Kelm MA, Hammerstone JF, Beecher G, Holden J, et al.: Concentrations of proanthocyanidins in common foods and estimations of normal consumption. J Nutr 134, 613–617, 2004.
  • Ariga T: The antioxidative function, preventive action on disease and utilization of proanthocyanidins. Biofactors 21, 197–201, 2004.
  • Kidd PM: Bioavailability and activity of phytosome complexes from botanical polyphenols: the silymarin, curcumin, green tea, and grape seed extracts. Altern Med Rev 14, 226–246, 2009.
  • Leonard SS, Xia C, Jiang BH, Stinefelt B, Klandorf H, et al.: Resveratrol scavenges reactive oxygenspecies and effects radical-induced cellular responses. Biochemical and Biophysical Research Communications 309, 1017–1026, 2003.
  • Eng ET, Ye J, Williams D, Phung S, Moore RE, et al.: Suppression of estrogen biosynthesis by procyanidin dimmers in red wine and grape seeds. Cancer Res 63, 8516–8522, 2003.
  • Jo JY, Gonzalez de Mejia E, and Lila MA: Effects of grape cell culture extracts on human topoisomerase II catalytic activity and characterization of active fractions. J Agric Food Chem 53, 2489–2498, 2005.
  • Obrink KJ and Rehbinder C: Animal definition: a necessity for the validity of animal experiments? Laboratory Animals 34, 121–130, 2000.
  • Working Committee for the Biological Characterization of Laboratory Animals/GV-Solas: Guidelines for specification of animals and husbandry methods when reporting the results of animal experiments. Laboratory Animals 19, 106–108, 2005.
  • Alfaro V: Specification of laboratory animal use in scientific articles: current low detail in the journal's instructions for authors and some proposals. Experimental and Clinical Pharmacology 27, 495–502, 2005.
  • Juni P, Altman DG, and Egger M: Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ 323, 42–46, 2001.
  • Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, et al.: The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 134, 663–694, 2001.
  • Festing MF and Altman DG: Guidelines for the design and statistical analysis of experiments using laboratory animals. ILAR Journal 43930, 244–258, 2002.
  • Dell RB, Holleran S, and Ramakrishnan R: Sample size determination. ILAR Journal 43, 207–213, 2002.
  • Berbata V, Luyten D, and Heard K: Emergency medicine animal research: does use of randomization and blinding affect the results? Academic Emergency Medicine 10, 684–687, 2003.
  • Macleod MR, van der Worp HB, Sena ES, Howells DW, Dirnagl U, et al.: Evidence for the efficacy of NXY-059 in experimental focal cerebral ischemia is confounded by study quality. Stroke 39, 2824–2829, 2008.
  • Kilkenny C, Parsons N, Kadyszewski E, Festing MFW, Cuthill IC, et al.: Survey of the quality of experimental design, statistical analysis and reporting of research using animals. PloS ONE 4(11), e7824, 2009. doi:10.1371/journal.pone.0007824
  • Speth PA, van Hoesel QG, and Haanen C. Clinical Pharmacokinet 15, 15–31, 1988.
  • Wouters KA, Kremer LC, Miller TL, Herman EH, and Lipshuttz SC: Protecting against anthracycline induced myocardial damage: A review of the most promising strategies. Br J Haematol 13, 561–578, 2005.
  • Horenstein MS, Vander Heide RS, and L'Ecuyer TJ: Molecular basis of anthracycline induced cardiotoxicity and its prevention. Mol Genet Metab 71, 436–444, 2000.
  • Doroshow JH, Locker GY, and Myers CE: Enzymatic defenses of the mouse heart against reactive oxygen metabolites: alterations produced by doxorubicin. J Clin Invest 65, 128–135, 1980.
  • Singal PK, Siveski-Iliskovic N, Hill M, Thomas TP, and Li T: Combination therapy with probucol prevents Adriamycin-induced cardiomyopathy. J Mol Cell Cardiol 27, 1055–1063, 1995.
  • Leonard SS, Xia C, Jiang BH, Stinefelt B, Klandorf H, et al.: Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses. Biochem Biophys Res Commun 309, 1017–1026, 2003.
  • Aoshima H, Satoh T, and Sakai N: Generation of free radicals during lipid hydroperoxide-triggered apoptosis in PC12h cells. Biochim Biophys Acta 1345, 35–42, 1997.
  • Lin KT, Xue JY, Nomen M, Spur B, and Wong PY. Peroxynitrite-induced apoptosis in HL-60 cells. J Biol Chem 270, 16487–16490, 1995.
  • Zhang B, Su Y, Ai G, Wang Y, Wang T, et al.: Involvement of peroxiredoxin I in protecting cells from radiation-induced death. J Radiat Res 46, 305–312, 2005.
  • Patt HM, Tyree EB, Straube RL, and Smith DE: Cysteine protection against X irradiation. Science 110, 213–214, 1949.
  • Yuhas, JM, Spellman JM, and Culo F: The role of WR-2721 in radiotherapy and/or chemotherapy. Cancer Clin Trials 3, 211–216, 1980.
  • Hooijmans CR, Rovers M, de Vries RB, Leenaars M, and Ritskes-Hoitinga M: An initiative to facilitate well informed decision making in laboratory animal research: report of the first international symposium on systematic reviews in laboratory animal science. Lab Anim 46, 356, 2012.
  • Sena ES, van der Worp HB, Bath PM, Howells DW, and Macleod MR: Publication bias in reports of animal stroke studies leads to major overstatement of efficacy. PLoS Biol 8(3), e1000344, 2010. doi:10.1371/journal.pbio.1000344
  • Clinical Trials.gov: Search for studies 2014. Available from http:clinicaltrials.gov/ct2/results?term=%22grape+seed+extract%22+AND+%22Cancer
  • Brooker S, Martin S, Pearson A, Bagchi D, Earl J, et al.: Double blind, placebo-controlled randomized phase II tiral of IH636 grape seed proanthocyanidin extract (GSPE) in patients with radiation-induced breast induration. Radiother Oncol 79, 45–51, 2006.
  • Mooiman KD, Maas-Bakker RF, Hendrix JJ, Bank PC, Rosing H, et al.: The effect of complementary and alternative medicines on CYP3A4 mediated metabolism of three different substrates: 7-benzyloxy-4-trifluoromethyl-coumarin, midazolam and docetaxel. J Pharm Pharmacol 66, 865–874, 2014. doi:10.1111/jphp. 12208
  • Wanwimolruk S, Wong K, and Wanwimolruk P: Variable inhibitory effect of different brands of commercial herbal supplements on human cytochrome P-450 CYP3A4. Drug Metabol Drug Interact 24, 17–35, 2009.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.